Trypanosoma brucei survives in the mammalian bloodstream by regularly changing its variant surface glycoprotein (VSG) coat. The active VSG gene is located in a telomeric expression site, and coat switching occurs either by replacing the transcribed VSG gene or by changing the expression site that is active. To determine whether VSG expression site control requires promoter-specific sequences, we replaced the active VSG expression site promoter in bloodstream-form T. brucei with a ribosomal DNA (rDNA) promoter. These transformants were fully infective in laboratory animals, and the rDNA promoter, which is normally constitutively active, was efficiently inactivated and reactivated in the context of the VSG gene expression site. As there is no sequence similarity between the VSG expression site promoter and the rDNA promoter, VSG expression site control does not involve sequences specific to the VSG expression site promoter. We conclude that an epigenetic mechanism, such as telomeric silencing, is involved in VSG expression site control in bloodstream-form T. brucei.
Summary
Trypanosoma brucei survives in the mammalian bloodstream by regularly changing its variant surface glycoprotein (VSG) coat. The active VSG gene is located in a telomeric expression site, and coat switching occurs either by replacing the transcribed VSG gene or by changing the expression site that is active. To determine whether VSG expression site control requires promoter-specific sequences, we replaced the active VSG expression site promoter in bloodstream-form T. brucei with a ribosomal DNA (rDNA) promoter. These transformants were fully infective in laboratory animals, and the rDNA promoter, which is normally constitutively active, was efficiently inactivated and reactivated in the context of the VSG gene expression site. As there is no sequence similarity between the VSG expression site promoter and the rDNA promoter, VSG expression site control does not involve sequences specific to the VSG expression site promoter. We conclude that an epigenetic mechanism, such as telomeric silencing, is involved in VSG expression site control in bloodstream-form T. brucei. (Kooter et al., 1987; Johnson et al., 1987; Pays et al., 198913 (Zomerdijk et al., 1990) .
The only distinguishing feature is an unusual DNA modification present only in inactive VSG expression sites (Bernards et al., 1984b; Pays et al., 1984; Gommers-Ampt et al., 1993 Figure  3) (Cross, 1975; Bernards et al., 1984a) . The 221 VSG gene in this variant is a single copy and is expressed in an expression site on chromosome 15 (Zomerdijk et al., 1990; Gottesdiener et al., 1990) . Prior to all experiments, the 221a variant was cloned (Carruthers and Cross, 1992) . Culturing was in laboratory rodents or in vitro in HMI-9 medium (Hirumi and Hirumi, 1989) Fiudenko et al. (1994) , except that the targeting flanks were derived from the promoter area of the 221 a expression site (Zomerdijk et al., 1990) instead of the dominant expression site (DES). A hygromycin resistance gene with tubulin RNA processing signals was used in all constructs (see Rudenko et al., 1994) . The enES2 construct has target fragments from the 221 expression site promoter area: 5' is a 190 bp Sall-Sphl and 3' is a 685 bp Sphl-Stul fragment. The ESZX construct has a 2.8 kb Sail 5'target fragment including the expression site promoter and extending into the 50 bp repeat array and a 875 bp Sall-Stul 3'target fragment (Zomerdijk et al., 1990) . In the RPZX construct, the expression site promoter was deleted (315 bp Hpal-Sal1 fragment) and replaced with the rDNA promoter on a 518 bp Alul fragment as described by Rudenko et al. (1994) . Upon integration of the enfS2 construct, the hygromycin gene was inserted into the Sphl site 272 bp downstream of transcription initiation, and the ES2X and RP2X constructs were integrated behind the Sail site 82 bp downstream of initiation (Zomerdijk et al., 1991 b; Pays et al., 1994) .
Transfection
T. brucei was electroporated essentially according to Carruthers et al. (1993) and selected on agarose plates with 2 vg of hygromycin B per milliliter.
T. brucei Relapse Experiments
In Vivo Relapses T. brucei that were to be relapsed were injected into mice that had been immunized with variant 221 a and treated with cyclophosphamide (0.3 mglg) 24 hr before challenge. Transformants (3 x 106) were injected into each mouse. T. brucei relapses were cloned (Carruthers and Cross, 1992) and checked by PCR for the single-copy 221a gene.
Loss of the gene would indicate a switch involving a duplicative gene conversion event into the 221 expression site. Presence of the 221a gene could indicate an in situ switch or a telomere exchange. PFG analysis was used to differentiate between these two posslbllmes. For the enES2 transformant, 2 out of 5 relapsed trypanosome clones analyzed had undergone an in situ switch. For the RP2X transformant, 7 out of 15 relapsed T. brucei clones had undergone an in situ switch. Using RT-PCR (Rudenko et al., 1994) , we amplified VSG cDNA from the relapsed T. brucei. cDNA identity was established using fingerprinting with restriction enzymes and using sequence analysis. The clones enESB7R7, RP2X-7R7, and RPZX-7R2 express the VO2 VSG gene, and enES2-7R2 expresses the 7.8 VSG gene (Michels et al., 1984) . In Vitro Relapses Relapsed T. brucei were switched back to the 221 expression site using selection with 20 pg of hygromycin B (for enES2 transformants) and 100 pg of hygromycin B (for RPX2 transformants) per milliliter. Colonies arising on the plates were expanded in the absence of drug.
DNA, RNA, and Protein Analyses Genomic DNA PFG electrophoresis was according to Zomerdijk et al. (1990) , with a switching time of 260 s. Southern blots were according to Sambrook et al. (1989) and were washed to an end stringency of 65°C in 0.1 x ssc. DNA Probes The hygromycin probe is a 680 bp fragment of the hygromycin resistance gene between the Ncol site and the stop codon (Gritz and Davies, 1983) . The 221 VSG gene-specific probe is the 590 bp Pstl fragment of TcV227.5 (Bernards et al., 1984a) . The tubulin probe is the 760 bp Hindlll-EcoRI fragment from pTbc@T-1 (Thomashow et al., 1983) . RNA Blots RNA was isolated with the guanidinium thiocyanate-cesium chloride procedure, electrophoresed in 1% formaldehyde gels, and blotted according to Sambrook et al. (1989) . Quantitation was with a Fuji BASZOOO Phosphorlmager. Protein Blots T. brucei protein preparations were made according to Ligtenberg et al. (1994) . After blotting, thefilterwas incubated with arabbit polyclonal antibody directed against purified 221 VSG protein (obtained from G. A. M. Cross). lmmunodetection was with enhanced chemiluminescence (Amersham).
These procedures were all according to Ligtenberg et al. (1994) .
